These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15707730)

  • 1. Application of experimental design methodology in development and optimization of drug release method.
    Kincl M; Turk S; Vrecer F
    Int J Pharm; 2005 Mar; 291(1-2):39-49. PubMed ID: 15707730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN).
    Ivic B; Ibric S; Betz G; Zorica D
    Arch Pharm Res; 2010 Jan; 33(1):103-13. PubMed ID: 20191351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment.
    Sabnis S; Rege P; Block LH
    Pharm Dev Technol; 1997 Aug; 2(3):243-55. PubMed ID: 9552452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
    Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
    Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and optimization of the drug release determination of iron from iron prolonged release tablets.
    Kincl M; Bibic R; Veber M; Vrecer F
    Pharmazie; 2003 Apr; 58(4):257-9. PubMed ID: 12749408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
    Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J
    Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid colorimetric assay of diclofenac sodium tablets using 4-carboxyl-2,6-dinitrobenzene diazonium ion (CDNBD).
    Idowu OS; Adegoke OA; Oderinu BA; Olaniyi AA
    Pak J Pharm Sci; 2006 Apr; 19(2):141-7. PubMed ID: 16751126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of dissolution behavior of diclofenac sodium extended release formulations under standard and biorelevant test conditions.
    Garbacz G; Weitschies W
    Drug Dev Ind Pharm; 2010 May; 36(5):518-30. PubMed ID: 19877827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
    Bertocchi P; Antoniella E; Valvo L; Alimonti S; Memoli A
    J Pharm Biomed Anal; 2005 Apr; 37(4):679-85. PubMed ID: 15797788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.
    Alsarra IA
    Boll Chim Farm; 2004 Dec; 143(10):359-64. PubMed ID: 15881815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology.
    Singh B; Chakkal SK; Ahuja N
    AAPS PharmSciTech; 2006 Jan; 7(1):E3. PubMed ID: 16584161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
    Abdullah MD; Bepary S; Rouf AS
    Pak J Pharm Sci; 2008 Jan; 21(1):70-7. PubMed ID: 18166523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form.
    Jantratid E; De Maio V; Ronda E; Mattavelli V; Vertzoni M; Dressman JB
    Eur J Pharm Sci; 2009 Jun; 37(3-4):434-41. PubMed ID: 19491035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and biopharmaceutical evaluation of osmotic pump tablets for controlled delivery of diclofenac sodium.
    Rani M; Surana R; Sankar C; Mishra B
    Acta Pharm; 2003 Dec; 53(4):263-73. PubMed ID: 14769233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution test for site-specific release isoniazid pellets in USP apparatus 3 (reciprocating cylinder): optimization using response surface methodology.
    Joshi A; Pund S; Nivsarkar M; Vasu K; Shishoo C
    Eur J Pharm Biopharm; 2008 Jun; 69(2):769-75. PubMed ID: 18191554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.